You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

discontinuation rate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Discontinuation Rate of Low-dose Levonorgestrel-releasing

Active, not recruiting
  • Hormonal Intrauterine Contraception
  • Low-dose levonorgestrel intrauterine systems (LNG-IUS)
  • Multiple Locations, Spain
    Many locations
Aug 10, 2022

Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

Not yet recruiting
  • Secondary Antibody Deficiency
  • Immunoglobulin replacement therapy (IGRT)
  • (no location specified)
Nov 4, 2022

Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

Unknown status
  • Persistent or Chronic ITP
  • Tpo-RA discontinuation
  • Creteil, France
    Henri-Mondor Hospital
Feb 17, 2020

Aggressive Non-Hodgkin Lymphoma Trial in Belgium, France (drug, other, procedure)

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
Jan 9, 2023

Synovial Tissue and Blood Signature of Rheumatoid Arthritis

Active, not recruiting
  • Rheumatoid Arthritis
  • Evaluation of subclinical inflammation
  • Brescia, Lombardia, Italy
  • +2 more
Mar 2, 2023

Contraception Trial in Tulsa (Kyleena Intrauterine System, Mirena Intrauterine System)

Recruiting
  • Contraception
  • Kyleena Intrauterine System
  • Mirena Intrauterine System
  • Tulsa, Oklahoma
    University of Oklahoma - Tulsa
Nov 7, 2022

Optimized Treatment and Surveillance of Hyperthyroidism

Recruiting
  • Hyperthyroidism
  • Graves Disease
  • Continuous heart rate monitoring
  • Basel, Switzerland
    University Hospital Basel
Nov 1, 2022

Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina Trial in Tampa (Estradiol vaginal cream)

Not yet recruiting
  • Pelvic Organ Prolapse
  • +3 more
  • Estradiol vaginal cream
  • Tampa, Florida
    University of South Florida
Oct 12, 2022

Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia
    • Montréal, Quebec, Canada
    • +25 more
    Jul 25, 2022

    Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Patritumab deruxtecan
    • (no location specified)
    May 9, 2023

    Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

    Not yet recruiting
    • Melanoma Stage IV
    • +3 more
    • (no location specified)
    Dec 14, 2022

    Discontinuation and Method Switching in Migori and Kitui

    Completed
    • Family Planning
    • Contraception
    • Enhancing contraceptive counseling on method continuation and switching
    • Kitui, Kenya
    • +1 more
    Oct 12, 2021

    Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

    Not yet recruiting
    • Advanced Solid Tumors With Neuroendocrine Differentiation
    • (no location specified)
    Nov 27, 2023

    Proton Pump Inhibitor, Inappropriate Drug Use, Discontinuation Trial (Patient Journey App, Information folder)

    Not yet recruiting
    • Proton Pump Inhibitor
    • +3 more
    • Patient Journey App
    • Information folder
    • (no location specified)
    Apr 20, 2022

    Lazertinib Dose Modification on Effectiveness and Safety

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Busan, Korea, Republic of
    • +10 more
    Jan 29, 2023

    HF Patients in HF Centers and Non-HF Centers in China

    Completed
    • Heart Failure
    • no intervention
    • Beijing, China
      Department of Cardiology, Peking University First Hospital
    Oct 22, 2023

    Febrile Neutropenia Trial (Early Discontinuation of Antibiotics, Standard of Care)

    Not yet recruiting
    • Febrile Neutropenia
    • Early Discontinuation of Antibiotics
    • Standard of Care
    • (no location specified)
    Mar 24, 2023

    Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • Oral Topotecan Combined With Anlotinib
    • Shanghai, China
      Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
    Feb 12, 2023

    Solid Malignancies Trial (Tisotumab Vedotin)

    Not yet recruiting
    • Solid Malignancies
    • Tisotumab Vedotin
    • (no location specified)
    May 9, 2023

    Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

    Not yet recruiting
    • Pancreatic Neoplasms
    • Shanghai, China
      Fudan University ShangHai Cancer Center
    Jul 31, 2023

    Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

    Recruiting
    • Sarcoma
    • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
    • Beijing, China
      Peking University People's Hospital
    Nov 6, 2023

    Study of Insulin Pump Discontinuation in Adults With Diabetes

    Completed
    • Diabetes Mellitus
    • Medical data collection
    • Corbeil-essonnes Cedex, France
      Centre Hospitalier Sud Francilien
    Sep 21, 2021

    Cardiomyopathy, Dilated Trial (Patients with cardiac function recovered for more than one year and discontinued were in the

    Not yet recruiting
    • Cardiomyopathy, Dilated
    • Patients with cardiac function recovered for more than one year and discontinued were in the discontinuation group.
    • (no location specified)
    Sep 8, 2023

    Anesthesia Trial in Daegu (Remimazolam, Desflurane)

    Recruiting
    • Anesthesia
    • Daegu, Korea, Republic of
      Daegu Catholic University Medical Center
    Mar 20, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 1, 2022